HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 96 filers reported holding HARVARD BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,872,727 | -16.5% | 668,076 | +6.6% | 0.00% | – |
| Q2 2023 | $3,441,571 | +542.4% | 626,880 | +391.5% | 0.00% | – |
| Q1 2023 | $535,718 | -24.2% | 127,552 | -50.0% | 0.00% | – |
| Q4 2022 | $706,638 | +116.1% | 255,104 | +100.0% | 0.00% | – |
| Q3 2022 | $327,000 | -28.8% | 127,552 | 0.0% | 0.00% | – |
| Q2 2022 | $459,000 | -90.1% | 127,552 | -82.8% | 0.00% | – |
| Q1 2022 | $4,614,000 | -7.0% | 742,929 | +5.6% | 0.00% | – |
| Q4 2021 | $4,961,000 | +3.7% | 703,755 | +2.6% | 0.00% | – |
| Q3 2021 | $4,786,000 | -16.4% | 685,695 | -0.3% | 0.00% | – |
| Q2 2021 | $5,727,000 | +76.0% | 687,498 | +15.3% | 0.00% | – |
| Q1 2021 | $3,254,000 | +19.2% | 596,034 | -6.4% | 0.00% | – |
| Q4 2020 | $2,731,000 | +95.4% | 636,713 | +37.1% | 0.00% | – |
| Q3 2020 | $1,398,000 | +8.0% | 464,325 | +11.1% | 0.00% | – |
| Q2 2020 | $1,295,000 | +5080.0% | 417,859 | +3546.6% | 0.00% | – |
| Q1 2020 | $25,000 | -80.6% | 11,459 | -72.9% | 0.00% | – |
| Q4 2019 | $129,000 | +9.3% | 42,254 | +9.9% | 0.00% | – |
| Q3 2019 | $118,000 | +57.3% | 38,460 | +3.0% | 0.00% | – |
| Q2 2019 | $75,000 | -96.7% | 37,352 | -92.8% | 0.00% | – |
| Q1 2019 | $2,242,000 | +40.3% | 520,084 | +3.5% | 0.00% | – |
| Q4 2018 | $1,598,000 | -40.9% | 502,435 | -2.5% | 0.00% | – |
| Q3 2018 | $2,704,000 | +6.0% | 515,140 | +7.9% | 0.00% | – |
| Q2 2018 | $2,552,000 | +1893.8% | 477,337 | +1764.5% | 0.00% | – |
| Q1 2018 | $128,000 | +66.2% | 25,601 | +11.2% | 0.00% | – |
| Q4 2017 | $77,000 | +40.0% | 23,027 | +58.8% | 0.00% | – |
| Q3 2017 | $55,000 | +48.6% | 14,498 | 0.0% | 0.00% | – |
| Q2 2017 | $37,000 | -2.6% | 14,498 | 0.0% | 0.00% | – |
| Q1 2017 | $38,000 | -15.6% | 14,498 | 0.0% | 0.00% | – |
| Q4 2016 | $45,000 | +9.8% | 14,498 | 0.0% | 0.00% | – |
| Q3 2016 | $41,000 | -2.4% | 14,498 | 0.0% | 0.00% | – |
| Q2 2016 | $42,000 | -95.6% | 14,498 | -95.4% | 0.00% | – |
| Q1 2016 | $955,000 | -8.2% | 316,644 | +5.7% | 0.00% | – |
| Q4 2015 | $1,040,000 | -4.1% | 299,626 | +4.4% | 0.00% | – |
| Q3 2015 | $1,085,000 | -30.0% | 287,040 | +5.6% | 0.00% | – |
| Q2 2015 | $1,550,000 | +1681.6% | 271,898 | +1712.9% | 0.00% | – |
| Q1 2015 | $87,000 | +2.4% | 14,998 | 0.0% | 0.00% | – |
| Q4 2014 | $85,000 | +25.0% | 14,998 | -9.1% | 0.00% | – |
| Q3 2014 | $68,000 | -9.3% | 16,498 | 0.0% | 0.00% | – |
| Q2 2014 | $75,000 | -95.3% | 16,498 | -95.1% | 0.00% | – |
| Q1 2014 | $1,584,000 | -50.9% | 334,281 | -53.2% | 0.00% | – |
| Q4 2013 | $3,228,000 | +90.0% | 714,061 | +121.1% | 0.00% | – |
| Q3 2013 | $1,699,000 | -0.1% | 322,940 | -10.2% | 0.00% | – |
| Q2 2013 | $1,701,000 | – | 359,513 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
| Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
| Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
| Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
| Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
| Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
| BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
| GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
| Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |